Kura Oncology (KURA) Tops Q4 EPS by 8c

Kura Oncology (NASDAQ: KURA) reported Q4 EPS of ($0.49), $0.08 better than the analyst estimate of ($0.57). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .

For earnings history and earnings-related data on Kura Oncology (KURA) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• FirstCash to acquire UK pawn operator Ramsdens for £206 million
• Primoris cuts 2026 outlook on renewables cost overruns, COO exits